Lupin receives FDA approval for generic Hydrocortisone Butyrate Lotion, 0.1%

Lupin’s Hydrocortisone Butyrate Lotion, 0.1% is the generic version of PreCision’s Locoid Lotion, 0.1 per cent

Pharma major Lupin announced that it has received final approval for its Hydrocortisone Butyrate Lotion, 0.1 per cent from the United States Food and Drug Administration (FDA) to market a generic version of PreCision Dermatology (PreCision) Locoid Lotion, 0.1 per cent.

Lupin’s Hydrocortisone Butyrate Lotion, 0.1% is the generic version of PreCision’s Locoid Lotion, 0.1 per cent. It is a corticosteroid indicated for the topical treatment of mild to moderate atopic dermatitis in patients 3 months of age and older.

Hydrocortisone Butyrate Lotion, 0.1 per cent had annual sales of approximately USD 13.8 million in the US.